Non-Invasive Cholesterol Reader Market Report 2026

Non-Invasive Cholesterol Reader Market Overview

• Non-Invasive Cholesterol Reader market size has reached to $1.3 billion in 2025 • Expected to grow to $2.63 billion in 2030 at a compound annual growth rate (CAGR) of 15.1% • Growth Driver: Increasing Prevalence Of Cardiovascular Diseases Fuelling The Growth Of The Market Amid Rising Sedentary Behaviors • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Non-Invasive Cholesterol Reader Market?

A non-invasive cholesterol reader refers to a medical device or diagnostic tool designed to measure cholesterol levels in the body without requiring blood samples or needles. These devices typically use technologies such as optical sensors, spectroscopy, or electromagnetic waves to detect cholesterol through the skin or other external means. The main product types of non-invasive cholesterol readers are wearable devices, handheld devices, and tabletop devices. Wearable devices are compact, body-mounted tools, such as patches, bands, or wristbands, designed to collect physiological data continuously or periodically with minimal intrusion. These devices employ technologies such as optical, ultrasound, electrical, and others. They are distributed online and offline and find applications in home care, hospitals and clinics, diagnostic centers, and others.

What Is The Non-Invasive Cholesterol Reader Market Growth Forecast?

The non-invasive cholesterol reader market size is expected to see rapid growth in the next few years. It will grow to $2.63 billion in 2030 at a compound annual growth rate (CAGR) of 15.1%. The growth in the forecast period can be attributed to AI-enabled diagnostics, integration with telemedicine, miniaturization of devices, expansion in emerging markets, continuous real-time monitoring. Major trends in the forecast period include optical sensor-based devices, wearable cholesterol monitoring, portable diagnostic devices, integration with mobile health apps, home-based cholesterol testing.

What Are The Drivers Of The Non-Invasive Cholesterol Reader Market?

The increasing prevalence of cardiovascular diseases is expected to propel the growth of the non-invasive cholesterol reader market going forward. Cardiovascular diseases are conditions affecting the heart and blood vessels, such as coronary artery disease, stroke, and heart failure. Cardiovascular diseases are increasing due to aging populations, as the risk of heart and blood vessel damage rises with age. A non-invasive cholesterol reader helps in cardiovascular diseases by quickly measuring cholesterol levels without blood samples, enabling early detection of high cholesterol and timely intervention to prevent heart attacks and strokes. For instance, in October 2024, according to the Centers for Disease Control and Prevention (CDC), a US-based government public health agency, in 2023, 919,032 deaths were caused by cardiovascular disease, representing about one-third of all fatalities. Therefore, the increasing prevalence of cardiovascular diseases is driving the growth of the non-invasive cholesterol reader industry. The rising healthcare expenditure is expected to propel the growth of the non-invasive cholesterol reader market going forward. Healthcare expenditure is the total spending on medical services, treatments, and health-related goods to maintain or improve population health. Healthcare expenditure is rising due to the increasing prevalence of chronic diseases, which require long-term treatments and continuous medical care, thereby significantly driving up overall healthcare costs. Higher healthcare spending supports non-invasive cholesterol readers by funding the development and adoption of easy-to-use diagnostic devices that help monitor cholesterol levels early and continuously, minimizing the need for expensive hospital visits and invasive procedures. For instance, in April 2025, according to the Office for National Statistics, a UK-based government agency, government-funded healthcare accounts for the majority of total health spending in the UK, reaching $346 billion (£258 billion) in 2024, which represents a 2.5% real-terms rise compared to 2023. Therefore, the rising healthcare expenditure is driving the growth of the non-invasive cholesterol reader industry.

Key Players In The Global Non-Invasive Cholesterol Reader Market

Major companies operating in the non-invasive cholesterol reader market are SiPhox Health Inc., Binah.ai Ltd., Occuity Ltd., PreVu Inc., CardioDiagnostics Inc., Scanadu Inc., Aidar Health Inc., Biovotion AG, Valencell Inc., Rockley Photonics Inc., LifeQ B.V., ChroniSense Medical Ltd., EchoLabs AI Inc., Grove Instruments LLC, MediBioSense Health Care, VitalConnect Inc., Sensible Medical Innovations Ltd., Current Health Ltd., Empatica Inc., BioIntelliSense Inc.

What Are Latest Mergers And Acquisitions In The Non-Invasive Cholesterol Reader Market?

In August 2024, the National University of Singapore, a Singapore-based research university, partnered with the Agency for Science, Technology and Research (A*STAR) to develop a non-invasive sensor capable of detecting cholesterol and glucose levels from the skin. With this partnership aims to develop and commercialize a wearable, hydrogel-based sensor for non-invasive, continuous, and real-time monitoring of cholesterol, glucose, and other biomarkers on dry skin to improve early disease detection, chronic disease management, and remote health monitoring. the Agency for Science, Technology and Research (A*STAR) is a Singapore-based public agency for economic-oriented research and development that offers the non-invasive cholesterol reader.

What Defines the Non-Invasive Cholesterol Reader Market?

The non-invasive cholesterol reader market consists of sales of non-invasive skin cholesterol detection system, stretchable hydrogel-based wearable sensor, and cholesterol monitor. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Non-Invasive Cholesterol Reader Market Report 2026?

The non-invasive cholesterol reader market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the non-invasive cholesterol reader industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.